Share on LinkedInShare on LinkedIn

ARTICLE · 13 NOVEMBER 2023

Michigan Senate Votes To Repeal Pharmaceutical Immunity From Product Liability Suits

Jones Day
Jones Day
Contributor
Jones Day

Jones Day

Jones Day is a global law firm with more than 2,400 lawyers in 40 offices across five continents....

View firm profile
Explore more from Jones Day

The Michigan Senate recently passed a bill to repeal a long-standing state law immunizing pharmaceutical manufacturers and sellers from product liability suits where the pharmaceutical products...

United StatesConsumer Protection

The Michigan Senate recently passed a bill to repeal a long-standing state law immunizing pharmaceutical manufacturers and sellers from product liability suits where the pharmaceutical products were approved by the U.S. Food and Drug Administration ("FDA").

If Senate Bill 410 is signed into law, Michigan could soon become an active jurisdiction for product liability cases against pharmaceutical companies and health care providers who distribute their products.

Michigan's Product Liability Act currently provides an absolute defense to the makers and sellers of FDA-approved pharmaceuticals in product liability suits unless the FDA determines that fraud or bribery influenced the approval process. Senate Bill 410 eliminates this immunity provision, leaving pharmaceutical manufacturers and sellers protected only by a rebuttable presumption that a pharmaceutical product is not defective if it conforms to the FDA's standards and regulations while subject to the company's

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from